Illumina, Inc. (ILMN)
NASDAQ: ILMN · Real-Time Price · USD
94.20
-3.00 (-3.09%)
At close: Feb 21, 2025, 4:00 PM
93.67
-0.53 (-0.56%)
After-hours: Feb 21, 2025, 7:45 PM EST
Illumina Employees
Illumina had 10,370 employees as of December 31, 2024. The number of employees decreased by 2,020 or -16.30% compared to the previous year.
Employees
10,370
Change (1Y)
-2,020
Growth (1Y)
-16.30%
Revenue / Employee
$421,601
Profits / Employee
-$117,936
Market Cap
14.92B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 10,370 | -2,020 | -16.30% |
Dec 31, 2023 | 12,390 | -970 | -7.26% |
Dec 31, 2022 | 13,360 | 1,610 | 13.70% |
Dec 31, 2021 | 11,750 | 2,400 | 25.67% |
Dec 31, 2020 | 9,350 | 1,650 | 21.43% |
Dec 29, 2019 | 7,700 | 400 | 5.48% |
Dec 30, 2018 | 7,300 | 1,100 | 17.74% |
Dec 31, 2017 | 6,200 | 700 | 12.73% |
Dec 31, 2016 | 5,500 | 900 | 19.57% |
Dec 31, 2015 | 4,600 | 900 | 24.32% |
Dec 28, 2014 | 3,700 | 700 | 23.33% |
Dec 29, 2013 | 3,000 | 800 | 36.36% |
Dec 31, 2012 | 2,200 | -200 | -8.33% |
Dec 30, 2012 | 2,400 | 300 | 14.29% |
Dec 31, 2011 | 2,100 | 319 | 17.91% |
Dec 31, 2010 | 1,781 | 245 | 15.95% |
Dec 28, 2008 | 1,536 | 495 | 47.55% |
Dec 30, 2007 | 1,041 | 445 | 74.66% |
Dec 31, 2006 | 596 | 221 | 58.93% |
Dec 31, 2006 | 375 | 97 | 34.89% |
Dec 31, 2005 | 278 | 42 | 17.80% |
Dec 28, 2003 | 236 | 3 | 1.29% |
Dec 29, 2002 | 233 | 54 | 30.17% |
Dec 30, 2001 | 179 | 74 | 70.48% |
Dec 31, 2000 | 105 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
ILMN News
- 1 day ago - Illumina and Broad Clinical Labs usher in new era of drug discovery with collaboration to rapidly scale single-cell solutions - PRNewsWire
- 3 days ago - Illumina unveils first-of-its-kind spatial transcriptomics technology - PRNewsWire
- 3 days ago - Illumina To Webcast Upcoming Investor Session at the Advances in Genome Biology and Technology (AGBT) Conference - PRNewsWire
- 9 days ago - Trump's Cuts to Medical Research Are Hurting These Stocks - Barrons
- 12 days ago - Illumina: Regulatory Risk In China And Weaker Sales Rebound Mask A Solid Rebound Of Its Profitability - Seeking Alpha
- 14 days ago - Illumina Analysts Slash Their Forecasts Following Q4 Results - Benzinga
- 15 days ago - Illumina, Inc. (ILMN) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 15 days ago - Illumina forecasts 2025 revenue largely below estimates - Reuters